The Bureau for Medical Services shall design and establish a wholesale prescription drug importation program in consultation with relevant stakeholders and federal agencies that will meet relevant requirements of 21 U.S.C. § 384, including safety and cost savings.  To establish this program, the bureau shall designate a state agency to become a licensed wholesaler for the purpose of seeking federal certification and approval to import safe prescription drugs at low cost for West Virginia’s consumers. The design and implementation of the program must conform to certain criteria, including: (1) The program shall use Canadian suppliers regulated under the appropriate Canadian and provincial laws;(2) The program shall have a process to sample the purity, chemical composition, and potency of imported products; (3) The program shall only import those prescription pharmaceuticals expected to generate substantial savings for West Virginia’s consumers; (4) The program shall ensure imported products will not be distributed, dispensed, or sold outside of West Virginia’s borders; (5) Voluntary participant, state-licensed, pharmacies and administering providers shall only charge individual consumers and health plans the actual acquisition cost of the imported, dispensed product and others.